INS and dementia: Preclinical studies suggest various mechanisms such as neuronal insulin resistance, impaired insulin signaling, inflammation, mitochondrial dysfunction, and vascular damage, which increase deposition of amyloid beta, tau proteins, and glycogen synthase kinase 3 beta (GSK3β), leading to an earlier onset of dementia in individuals with an impaired glucose metabolism.30